Cargando…

Oligomers of hepatitis A virus (HAV) capsid protein VP1 generated in a heterologous expression system

BACKGROUND: The quasi-enveloped picornavirus, Hepatitis A Virus (HAV), causes acute hepatitis in humans and infects approximately 1.5 million individuals a year, which does not include the asymptomatically infected population. Several severe outbreaks in developing nations in recent years have highl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nain, Anshu, Kumar, Mohit, Banerjee, Manidipa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991588/ https://www.ncbi.nlm.nih.gov/pubmed/35392916 http://dx.doi.org/10.1186/s12934-022-01780-x

Ejemplares similares

Detection of Antibodies against Hepatitis A Virus (HAV) by a Surface Plasmon Resonance (SPR) Biosensor: A New Diagnosis Tool Based on the Major HAV Capsid Protein VP1 (SPR-HAVP1)
por: dos Santos, Gabriel Menezes Costa, et al.
Publicado: (2021)

The C-terminal region of the non-structural protein 2B from Hepatitis A Virus demonstrates lipid-specific viroporin-like activity
por: Shukla, Ashutosh, et al.
Publicado: (2015)

Cysteine Residues in the Major Capsid Protein, Vp1, of the JC Virus Are Important for Protein Stability and Oligomer Formation
por: Kobayashi, Shintaro, et al.
Publicado: (2013)

Hepatitis A virus (HAV) packaging size limit
por: Konduru, Krishnamurthy, et al.
Publicado: (2009)

Increased Clinical Signs and Mortality in IFNAR((−/−)) Mice Immunised with the Bluetongue Virus Outer-Capsid Proteins VP2 or VP5, after Challenge with an Attenuated Heterologous Serotype
por: Attoui, Houssam, et al.
Publicado: (2023)

Viability RT-qPCR to Distinguish Between HEV and HAV With Intact and Altered Capsids
por: Randazzo, Walter, et al.
Publicado: (2018)

Generation of Antibodies against Foot-and-Mouth-Disease Virus Capsid Protein VP4 Using Hepatitis B Core VLPs as a Scaffold
por: Swanson, Jessica, et al.
Publicado: (2021)

Vaccination With Recombinant Adenoviruses Expressing the Bluetongue Virus Subunits VP7 and VP2 Provides Protection Against Heterologous Virus Challenge
por: Rojas, José Manuel, et al.
Publicado: (2021)

Molecular Characterization of Outer Capsid Proteins VP5 and VP7 of Grass Carp Reovirus
por: Zhang, Fuxian, et al.
Publicado: (2022)

High Cooperativity of the SV40 Major Capsid Protein VP1 in Virus Assembly
por: Mukherjee, Santanu, et al.
Publicado: (2007)

Improper Tagging of the Non-Essential Small Capsid Protein VP26 Impairs Nuclear Capsid Egress of Herpes Simplex Virus
por: Nagel, Claus-Henning, et al.
Publicado: (2012)

Sporadic Hepatitis A Virus PCR False-Positive Results Observed during Reflex Testing of Serum Samples Previously Tested for Anti-HAV Antibodies and Caused by Contamination with HAV RNA Present in the Reagents of the Commercial Anti-HAV Immunoassay
por: Lunar, Maja M., et al.
Publicado: (2023)

Hepatic inflammation resulting from localized, subcutaneous expression of Parvovirus VP1u capsid protein: Importance and implication
por: Adamson-Small, Laura A, et al.
Publicado: (2016)

Protection of IFNAR (−/−) Mice against Bluetongue Virus Serotype 8, by Heterologous (DNA/rMVA) and Homologous (rMVA/rMVA) Vaccination, Expressing Outer-Capsid Protein VP2
por: Jabbar, Tamara Kusay, et al.
Publicado: (2013)

Molecular Evolution and Genetic Analysis of the Major Capsid Protein VP1 of Duck Hepatitis A Viruses: Implications for Antigenic Stability
por: Ma, Xiuli, et al.
Publicado: (2015)

Interaction between Bluetongue virus outer capsid protein VP2 and vimentin is necessary for virus egress
por: Bhattacharya, Bishnupriya, et al.
Publicado: (2007)

Prevalence of HAV and HEV in the patients presenting with acute viral hepatitis
por: Rao, Pooja, et al.
Publicado: (2012)

A Recombinant HAV Expressing a Neutralization Epitope of HEV Induces Immune Response against HAV and HEV in Mice
por: Kui, Xiang, et al.
Publicado: (2017)

A simple and rapid Hepatitis A Virus (HAV) titration assay based on antibiotic resistance of infected cells: evaluation of the HAV neutralization potency of human immune globulin preparations
por: Konduru, Krishnamurthy, et al.
Publicado: (2008)

Identifying t-cell epitopes of the VP1 capsid protein of human rhinovirus
por: Gaido, Cibele Marina, et al.
Publicado: (2015)

In-hospital post-transplant acute hepatitis A viral (HAV) infection in a liver transplant recipient who was HAV seropositive pre-transplant
por: Zhu, Julie, et al.
Publicado: (2019)

Hepatitis A virus infection: Is it an important hazard to public health?: hazards of HAV for public health
por: Saberifiroozi, Mehdi
Publicado: (2011)

Health economic assessment of universal immunization of toddlers against Hepatitis A Virus (HAV) in Mexico
por: Carlos, Fernando, et al.
Publicado: (2015)

Synthesis and testing of azaglutamine derivatives as inhibitors of Hepatitis A Virus (HAV) 3C proteinase
por: Huang, Yanting, et al.
Publicado: (1999)

Expression of enterovirus 71 capsid protein VP1 in Escherichia coli and its clinical application
por: Shi, Mei, et al.
Publicado: (2014)

Polyvalent Human Immune Globulin: A Prospective, Open-Label Study Assessing Anti-Hepatitis A Virus (HAV) Antibody Levels, Pharmacokinetics, and Safety in HAV-Seronegative Healthy Subjects
por: Kankam, Martin, et al.
Publicado: (2020)

Strain-Specific Interactions between the Viral Capsid Proteins VP4, VP7 and VP6 Influence Rescue of Rotavirus Reassortants by Reverse Genetics
por: Valusenko-Mehrkens, Roman, et al.
Publicado: (2023)

Crystallization and preliminary crystallographic analysis of the major capsid proteins VP16 and VP17 of bacteriophage P23-77
por: Rissanen, Ilona, et al.
Publicado: (2012)

Construction and immune evaluation of the recombinant duck adenovirus type 3 delivering capsid protein VP1 of the type 1 duck hepatitis virus
por: Wen, Yongsen, et al.
Publicado: (2023)

Changes in hepatitis A virus (HAV) seroprevalence in medical students in Bangkok, Thailand, from 1981 to 2016
por: Sintusek, Palittiya, et al.
Publicado: (2018)

HAV Immunity in Iranian Medical Students
por: Hosseini Shokouh, Seyyed Javad, et al.
Publicado: (2015)

No IL-18BP? Avoid HAV
por: Diamond, Michael S.
Publicado: (2019)

HAV Infection Associated with Hemophagocytic Syndrome
por: Aamri, H., et al.
Publicado: (2023)

Nachrichten des Deutschen Hausärzteverbands (HÄV)
Publicado: (2023)

Antigenic heterogeneity of capsid protein VP1 in foot-and-mouth disease virus (FMDV) serotype Asia 1
por: Alam, SM Sabbir, et al.
Publicado: (2013)

Recombinant Lactobacillus casei Expressing Capsid Protein VP60 can Serve as Vaccine Against Rabbit Hemorrhagic Disease Virus in Rabbits
por: Wang, Li, et al.
Publicado: (2019)

Acute bilateral granulomatous anterior uveitis as an extra-hepatic manifestation of hepatitis A virus (HAV) infection: a case report
por: Azimi, Ali, et al.
Publicado: (2020)

Detection of Parechovirus A1 with Monoclonal Antibody against Capsid Protein VP0
por: Kung, Ming-Hsiang, et al.
Publicado: (2020)

Comparative Proteomic Analysis Reveals Mx1 Inhibits Senecavirus A Replication in PK-15 Cells by Interacting with the Capsid Proteins VP1, VP2 and VP3
por: Gao, Hang, et al.
Publicado: (2022)

Alteration of amino acid 101 within capsid protein VP-1 changes the pathogenicity of Theiler's murine encephalomyelitis virus
Publicado: (1989)

Cannot write session to /tmp/vufind_sessions/sess_qmqpifbokte7p38fsd8hv0iv0j